In addition, a PAX3-FOXO1 fusion protein hampered the differentiation of rhabdomyosarcoma cells [284], supporting a potential anti-tumorigenic connection among FOXO1, type I myofiber phenotype, and cancer. Here, FOXO1 is linked to rhabdomyosarcoma.